Watch Expert Video: RNA sequencing with WES/WGS improves variant interpretation for rare disease diagnostics
Baylor Genetics experts Dr. Christine Eng, CMO, CQO, and Dr. Xiaonan Zhao, Associate Clinical Director, discuss the transformative role of RNAseq with WES/WGS in complex and rare disease diagnostics.
Key Highlights:
- The evolution and significance of RNAseq in clinical settings
- Comprehensive testing processes and criteria for variant
eligibility at Baylor Genetics - How RNAseq has been utilized to clarify variants identified through WES/WGS
Please complete the form to access this exclusive content.